title: [Combination of methotrexate injection through hysteroscopic tubal catheterization and mifepristone per os in the conservative treatment of tubal pregnancy].
abstract: OBJECTIVE
  To evaluate the value of the combination of methotrexate(MTX) injection through hysteroscopic tubal catheterization and mifepristone per os in the conservative treatment of tubal pregnancy.
  
  
  METHODS
  Forty patients who met the criteria of conservative treatment were enrolled in this study and received the combined therapy of MTX 50 mg/d injection through hysteroscopic tubal catheterization and oral mifepristone 100mg/d for 5 days.
  
  
  RESULTS
  Of these 40 patients, 38 (95.0%) were cured. The human chorionic gonadotropin decreased to normal level within 3-48 days. The masses disappeared within 16-65 days. The menstruation returned normal within 28-42 days. No obvious side effect was observed. Of 30 patients who underwent hydrotubation through hysteroscopy three months later, 12 patients were unobstructed, 2 patients were completely obstructed, and 16 patients were partially obstructed. Five patients had full-term deliveries up to this report.
  
  
  CONCLUSIONS
  The combination of MTX injection through hysteroscopic tubal catheterization and mifepristone per os is safe and effective for early tubal pregnancy.
authors.affiliation: Deparment of Obestetrics and Gynecology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
authors.forename: Hui
authors.initials: H
authors.lastname: Zhao
authors.forename: Bao-Jun
authors.initials: BJ
authors.lastname: Yang
authors.forename: Li-Min
authors.initials: LM
authors.lastname: Feng
mesh_terms: D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015907:Hysteroscopy; D007267:Injections; D008727:Methotrexate / Q000008:administration & dosage* / Q000627:therapeutic use; D015735:Mifepristone / Q000627:therapeutic use*; D011247:Pregnancy; D011274:Pregnancy, Tubal / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D015735:Mifepristone; D008727:Methotrexate